Loading stock data…
MDAI
$2.15+0.10 (+4.88%)
Market ClosedLast close May 1
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Spectral AI, Inc. in the Healthcare sector is trading at $2.15. The stock is currently 33% below its 52-week high of $3.21, remaining 16.2% above its 200-day moving average. Technical signals show neutral RSI of 67 and bullish MACD crossover, explaining why MDAI maintains its current momentum and trend strength. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Overbought levels (RSI 67) — risk of consolidation or pullback
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$2.15
Potential Upside
5%
Whystock Fair Value$2.26
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damag...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$58.56M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.91
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
132.20%
Volume
Today's trading volume
558,626
Recent News
Spectral AI, Inc. Q4 2025 Earnings Call Summary
Moby summary of Spectral AI, Inc.'s Q4 2025 earnings call
Spectral AI (MDAI) Q4 2025 Earnings Transcript
Before we begin, I'd like to remind everyone that during this call, certain statements made are forward-looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the company's strategy, plans, objectives, initiatives and financial outlook. When used in this call, the words estimates, projected, expects, anticipates, forecasts, plans, intends, believes, seeks, may, will, should, future, propose and variations of these words or similar expressions or the negative versions of such words or expressions are intended to identify forward-looking statements. As such, listeners are cautioned not to place undue reliance on any forward-looking statements.
Spectral AI Inc (MDAI) Q4 2025 Earnings Call Highlights: Navigating Challenges and Seizing ...
Spectral AI Inc (MDAI) reports a significant reduction in net loss and strong cash position, while preparing for commercialization amidst revenue challenges.
Spectral AI Q4 Earnings Call Highlights
Spectral AI (NASDAQ:MDAI) executives said fiscal 2025 marked a “pivotal year” as the company advanced its DeepView burn diagnostic system toward potential FDA clearance and strengthened its funding profile, highlighted by a new award under its longstanding BARDA partnership. DeepView FDA path and c
An Intrinsic Calculation For Spectral AI, Inc. (NASDAQ:MDAI) Suggests It's 25% Undervalued
Key Insights Using the 2 Stage Free Cash Flow to Equity, Spectral AI fair value estimate is US$2.15 Spectral AI is...